Method of functionalization of a biopolymer and method of cross-linking thereof

HK40137347APending Publication Date: 2026-09-11POLBIONICA SP Z O O
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62026124409
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-03-23
Filing Date
2026-06-05
Publication Date
2026-09-11

Smart Images

  • Figure 00000008_0000
    Figure 00000008_0000
  • Figure 00000025_0000
    Figure 00000025_0000
  • Figure 00000026_0000
    Figure 00000026_0000
Patent Text Reader

Abstract

The invention relates to a method for functionalizing a biopolymer, in which a biopolymer having-OH or-NH2 groups is reacted with at least one compound containing at least one C = C or C = C bond and a UV-Vis radiation-absorbing chromophore directly adjacent to the bond. The invention also relates to a process for obtaining a solid biopolymer material, wherein the functionalized biopolymer obtained by the above process undergoes reversible crosslinking upon exposure to light in the UV-VIS range. The invention also relates to the use of the functionalized biopolymer as a support material for 3D bioprinting and to the use of the functionalized biopolymer for producing a structure selected from spheroids, organoids, artificial organs, envelopes and tissue models.
Need to check novelty before this filing date? Find Prior Art

Description

(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480021420.X (22) Application Date 2024.03.22 (30) Priority Data 23461537.5 2023.03.23 EP (85) PCT International Application Entering National Phase Date 2025.09.23 (86) PCT International Application Application Data PCT / PL2024 / 050023 2024.03.22 (87) PCT International Application Publication Data WO2024 / 196271 EN 2024.09.26 (71) Applicant: Polbionica S.A. Address: Gula, Poland (72) Inventors: S. Domanski, A. Zakrzewska, M. Wozola, M. Clark (74) Patent Agency: Beijing Longan Law Firm, 11323 Patent Attorney: Quan Xianzhi (51) Int.Cl. C08B 37 / 08 (2006.01) C08H 1 / 06 (2006.01) C08L 5 / 08 (2006.01) C08L 89 / 06 (2006.01) B29C 64 / 40 (2006.01) C12N 5 / 00 (2006.01) (54) Invention Title: Functionalization Method of Biopolymer and Crosslinking Method Thereof (57) Abstract: This invention relates to a method for functionalizing biopolymers, The invention relates to a method for obtaining solid biopolymer materials, wherein the functionalized biopolymer obtained by the above method undergoes reversible cross-linking upon exposure to light in the UV-VIS range. The invention also relates to the use of functionalized biopolymers as support materials for 3D bioprinting, and their use in producing structures selected from spheres, organoids, artificial organs, membranes, and tissue models. Claims 1 page, Description 17 pages, Drawings 15 pages, CN 121100136 A 2025.12.09 CN 1 21 10 01 36 A 1. A method for functionalizing a biopolymer, characterized in that the biopolymer having a -OH or -NH2 group reacts with at least one compound, said compound containing at least one C=C or C≡C bond and a chromophore directly adjacent to said bond that absorbs UV-Vis radiation. 2. The method according to claim 1, wherein the compound containing at least one C=C or C≡C bond is a carboxylic acid derivative, preferably selected from active esters, acid anhydrides, and acyl chlorides.3. The method according to claim 2, wherein the carboxylic acid derivative is selected from coumarin-3-carboxylic acid derivatives, exo-5-norbornene carboxylic acid derivatives, and trans-cinnamic acid derivatives. 4. The method according to claim 2 or 3, wherein the active ester is an N-hydroxysuccinimide ester, obtained by reacting a carboxylic acid containing at least one C=C or C≡C bond with an N-hydroxysuccinimide in the presence of a coupling agent, wherein the coupling agent is preferably selected from 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), dicyclohexyl-carbodiimide (DCC), and N,N'-diisopropylcarbodiimide (DIC). 5. The method according to any one of claims 1-4, wherein the biopolymer is selected from proteins and polysaccharides. 6. The method according to claim 5, wherein the biopolymer is selected from gelatin, hyaluronic acid, alginate, chitosan, dextran, starch, cellulose, collagen, chitin, carrageenan, inulin, glycogen, and heparin, preferably selected from gelatin, chitosan, and hyaluronic acid, and most preferably gelatin. 7. A method for obtaining a solid biopolymer material, characterized in that the functionalized biopolymer obtained by the method according to any one of claims 1-6 undergoes reversible cross-linking when exposed to light in the UV-VIS range, preferably in the light range of wavelengths 280-800 nm, and most preferably in the light range of 365 nm and 405 nm. 8. Use of the functionalized biopolymer obtained by the method according to any one of claims 1-6 as a support material for 3D bioprinting. 9. Use of the functionalized biopolymer obtained by the method according to any one of claims 1-6 for preparing structures selected from spheres, organoids, artificial organs, membranes, and tissue models. Claims 1 / 1 page 2 CN 121100136 A Functionalization Method of Biopolymers and Crosslinking Method Technical Field

[0001] This invention relates to a method for functionalizing biopolymers, wherein a biopolymer having -OH or -NH2 groups reacts with at least one compound, said compound containing at least one C=C or C≡C bond and a chromophore directly adjacent to said bond that absorbs UV-VIS radiation. This invention also relates to a method for obtaining solid biopolymer materials, wherein the functionalized biopolymer obtained by the above method undergoes reversible crosslinking when exposed to light in the UV-VIS range. This invention also relates to the use of functionalized biopolymers as 3D bioprinting support materials, and the use of functionalized biopolymers for producing structures selected from spheres, organoids, artificial organs, coatings, and tissue models. This invention is used in tissue engineering, transplantation, and medical and pharmacological research. Background Art

[0002] Chemical compounds that can participate in cycloaddition reactions are used in the crosslinking reactions of natural polymers (PelláMCG, Lima-Tenório MK).,Tenório‑Neto ET ,Guilherme MR ,Muniz EC ,Rubira AF .Chitosan‑based hydrogels:From preparation to biomedical applications.Carbohydr Polym.2018, 196,233‑245,doi:10.1016 / j.carbpol.2018.05.033;Eva Mueller,lsabelle Poulin , William James Bodnaryk,and Todd Hoare,Click Chemistry Hydrogels for Extrusion Bioprinting:Progress,Challenges,and Opportunities,Biomacromolecules 2022 23 (3) ,619‑640 ,doi:10 .1021 / acs .biomac .1c01105;Kerim M ,Gattás‑Asfura ,Eric Weisman ,Fotios M .Andreopoulos ,Miodrag Micic ,BillMuller ,Sanjeev Sirpal , SiM.Pham,and Roger M.Leblanc,Nitrocinnamate‑Functionalized Gelatin:Synthesis and“Smart”Hydrogel Formation via Photo‑Cross‑Linking,Biomacromolecules 2005 6 (3) ,1503‑1509,doi:10.1021 / bm049238w;KoshyST,Desai RM,Joly P,Li J,Bagrodia RK, Lewin SA ,Joshi NS ,Mooney DJ .Click‑Crosslinked Injectable Gelatin Hydrogels.Adv Healthc Mater.2016,5(5) ,541‑7,doi:10.1002 / adhm.201500757;Jasper Van Hoorick,Liesbeth Tytgat,Agnes Dobos,Heidi Ottevaere,Jürgen Van Erps,HugoThienpont, Aleksandr Ovsianikov, Peter Dubruel, Sandra Van Vlierberghe, (Photo-) crosslinkable gelatin derivatives for biofabrication applications, Acta Biomaterialia 2019, 97, 46-73, doi:10.1016 / j, actbio.2019.07.035).

[0003] However, there is still a need to provide new methods for functionalizing biopolymers that can be crosslinked under light alone (whether in 3D bioprinting or in other techniques for forming solid biopolymer structures, such as molding), i.e., without using initiating additives for crosslinking, such as photoinitiators, metal salts, transition metal complexes, and high-valent iodine compounds, which constitute undesirable contaminants in the target structure. In particular, it is desirable to eliminate photoinitiators, which have the greatest cytotoxic effect on cells that may constitute components of the crosslinked biopolymer material.

[0004] Furthermore, there is always a need to provide novel functionalized biopolymers capable of crosslinking under longer wavelengths (i.e., lower energy) of light, as this not only reduces the energy consumption of the crosslinking process but, more importantly, limits the negative impact of UV radiation on the survival rate of cells contained in the crosslinked biopolymer material. In addition, there is always a need to provide novel functionalized biopolymers capable of reversible crosslinking under light, which in some applications can significantly facilitate improvements to or more detailed analysis of the structure of the formed biopolymer. Summary of the Invention

[0005] The subject of this invention is a method for functionalizing biopolymers, wherein a biopolymer having -OH or -NH2 groups reacts with at least one compound containing at least one C=C or C≡C bond and a chromophore that absorbs UV-Vis radiation, and the chromophore absorbing UV-Vis radiation is adjacent to this bond. In the context of this document, adjacent means that the chromophore is connected to a carbon atom directly adjacent to the carbon atom of the multi-bonded carbon atom. Preferably, the compound containing at least one C=C or C≡C bond is a carboxylic acid derivative, preferably selected from active esters, acid anhydrides, and acyl chlorides. Preferably, the carboxylic acid derivative is selected from coumarin-3-carboxylic acid derivatives, exo-5-norbornene-carboxylic acid derivatives, and trans-cinnamic acid derivatives. Preferably, the active ester is an N-hydroxysuccinimide ester, obtained by reacting a carboxylic acid containing at least one C=C or C≡C bond with an N-hydroxysuccinimide in the presence of a coupling agent, preferably selected from 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), dicyclohexyl-carbodiimide (DCC), and N,N'-diisopropylcarbodiimide (DIC).

[0006] Preferably, the biopolymer is selected from proteins and polysaccharides. In a preferred embodiment of the invention, the biopolymer is selected from gelatin, hyaluronic acid, alginate, chitosan, dextran, starch, cellulose, collagen, chitin, carrageenan, inulin, glycogen, and heparin, preferably from gelatin, chitosan, and hyaluronic acid, and most preferably from gelatin.

[0007] The subject of the invention is also a method for obtaining solid biopolymer materials, wherein the functionalized biopolymer obtained by the above method undergoes reversible cross-linking under UV-VIS light irradiation, preferably light in the wavelength range of 280-800 nm, and most preferably wavelengths selected from 365 nm and 405 nm.

[0008] The subject of the invention is also the use of the functionalized biopolymer obtained by the above method as a support material for 3D bioprinting.

[0009] The subject of the invention is also the use of the functionalized biopolymer obtained by the above method for producing structures selected from spheres, organoids, artificial organs, coatings, and tissue models.

[0010] Functionalized biopolymers obtained using the method according to the invention allow for the acquisition of fully crosslinked solutions in the range of 0.5% to 50% without the addition of photoinitiators such as lithium phenyl-2,4,6-trimethylbenzoylphosphonate (LAP) or 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylphenylacetone (Irgacure 2959). Functionalized biopolymers with molecular weights in the range of 1000 kDa to 500000 kDa, such as gelatin, hyaluronic acid, alginate, and other polymers of natural or semi-synthetic origin, having a degree of substitution of 10% to 100%, wherein the substituents are compounds containing at least one C=C or C≡C bond and a chromophore directly adjacent to that bond that absorbs UV-Vis radiation.

[0011] The functionalized biopolymers obtained by the method according to the invention remain completely soluble in aqueous environments (volume from 0.1 to 1000 ml), including physiological saline solutions or cell culture media with a pH of 4 to 8, depending on the application.

[0012] The functionalized biopolymers obtained by the method according to the invention are suitable for extrusion, volumetric printing, and other 3D printing technologies that require the use of materials with appropriate viscosity and clear gel points to obtain uniform and coherent fibers, thereby maintaining print resolution. Depending on the concentration of the prepolymer solution used, the printing temperature can range from 5°C to 50°C, and in this case, the prepolymer should be understood as the functionalized biopolymer according to the invention before the crosslinking process begins. The printing pressure in extrusion printing is typically in the range of 5 to 150 kPa. The printing speed is typically in the range of 1 to 100 mm / s. The needle diameter is typically in the range of 50 to 900 μm. The printed model can include any size expressed in millimeters.And a fill power of 5% to 100%, which means that solid and cutout printing can be obtained.

[0013] When exposed to light with a wavelength of 280 nm to 800 nm and a power of 1 mW / cm2 to 1000 mW / cm2 for 10 to 720 seconds, the functionalized biopolymer obtained by the method according to the invention is fully cross-linked in the absence of a photoinitiator.

[0014] The functionalized biopolymer obtained by the method according to the invention is fully applicable to 3D culture, tissue engineering and other live cell applications using UV-Vis light as a cross-linking factor. This technique does not require the use of external initiators that may have potential cytotoxic effects.

[0015] The functionalized biopolymer obtained using the method according to the invention can be used as a single material in bio-inks or as an additive in mixtures of other printable materials. This means that during 3D bioprinting, functionalized biopolymers undergo cross-linking. This cross-linking reaction can occur not only between molecules of one type of functionalized biopolymer, but also between molecules of two or more different functionalized biopolymers. Functionalized biopolymers, or mixtures of biopolymers functionalized with various compounds, can constitute 0.1% to 99.9% of the total mixture.

[0016] The functionalized biopolymers or blends thereof according to the invention have potential applications in biological research that uses a reference L929 cell line in the initial stages of the study, or, provided that the same or similar MTT test results are obtained, uses alternative cell lines according to ISO 10993-5, namely CCL 1 (NCTC clone 929), CCL 163 (Balb / 3T3 clone A31), CCL171 (MRC-5), CCL 75 (WI-38), CCL81 (Vero), CCL10 (BHK-21[C-13]), and V-79 379A, and uses a specific cell line consistent with the application in subsequent stages of the study. The functionalized biopolymers according to the invention, blends thereof, and materials with added cell lines can be homogenized using syringe mixing techniques or specialized cell mixers for biological applications.

[0017] The subject matter of the invention in embodiments is illustrated in the accompanying drawings in a manner that does not limit the scope of the invention, wherein:

[0018] FIG1 shows the 1H NMR spectrum of the material obtained during the crosslinking process of coumarin-3-carboxylic acid-functionalized gelatin in Example 1;

[0019] FIG2a shows the 1H NMR spectrum of exo-5-norborneolene carboxylic acid;

[0020] FIG2b shows the material obtained during the crosslinking process of a mixture of a 15% solution of coumarin-3-carboxylic acid-functionalized gelatin and a 15% solution of exo-5-norborneolene carboxylic acid-functionalized gelatin in Example 2.1H NMR spectra;

[0021] Figure 3a shows the 1H NMR spectrum of trans-cinnamic acid;

[0022] Figure 3b shows the 1H NMR spectrum of the material obtained during the crosslinking process of a mixture of a 15% solution of coumarin-3-carboxylic acid-functionalized gelatin and a 10% solution of trans-cinnamic acid-functionalized gelatin in Example 3;

[0023] Figure 3c shows the 1H NMR spectrum of the material obtained during the crosslinking process of a mixture of a 15% solution of coumarin-3-carboxylic acid-functionalized gelatin and a 15% solution of trans-cinnamic acid-functionalized gelatin in Example 3;

[0024] Figure 4 shows photographs of printed flake-like scaffolds at different crosslinking times;

[0025] Figure 5 shows the 1H NMR spectrum of a 15% solution of coumarin-3-carboxylic acid-functionalized gelatin (GelCM);

[0026] Figure 6 shows the 1H NMR spectrum of a 12.5% ​​GelCM solution;

[0027] Figure 7 shows the 1H NMR spectrum of a 10% GelCM solution;

[0028] Figure 8 shows the scheme of the g.code file [template.gcode];

[0029] Figure 9 shows a diagram of the fiber bending test platform;

[0030] Figure 10 shows a microscopic image of the construct in the fiber bonding test;

[0031] Figure 11 shows the percentage of fiber diffusion rate Dfr in the fiber bonding test;

[0032] Figure 12 shows the printability of Pr in the fiber bonding test; Specification 3 / 17 pages 5 CN 121100136 A

[0033] Figure 13 shows the Almar Blue test results of cells printed with constructs of 10%, 12.5%, and 15% GelCM and 10% gelatin methacrylate (GelMA);

[0034] Figure 14 shows a microscopic image of the printed construct with L929 cells immediately after the printing process;

[0035] Figure 15 shows a microscopic image of the printed construct with L929 cells on day 3 of the experiment;

[0036] Figure 16 shows a microscopic image of the printed construct with L929 cells on day 7 of the experiment;

[0037] Figure 17 shows a photograph of the biological material with L-929 cells after being transferred to a 6-well plate containing supplemental culture medium, wherein A-GELMA 10%, GelCM 12.5%, GelCM 15%, and B-GelCM 10%;

[0038] Figure 18 shows the percentage of lactate dehydrogenase (LDH) released from L-929 cells as a result of interaction with the test biological material for 1, 5, 7, and 14 days;

[0039] Figure 19 shows a microscopic photograph of L-929 cell culture exposed to biological material GelCM 10%, GelCM 12.5%, GelCM 15%, and GELMA 10% after 14 days of incubation. Detailed Embodiments

[0040] This invention relates to a method for functionalizing biopolymers, wherein a biopolymer having -OH or -NH2 groups reacts with at least one compound containing at least one C=C or C≡C bond (activated or inactivated), i.e., a bond capable of undergoing a cycloaddition reaction 2+2, and a chromophore that absorbs UV-Vis radiation.

[0041] The main objective of the method according to the invention is to obtain appropriately functionalized derivatives of natural polymers (described below and shown as Helix / P) for tissue engineering, including 3D bioprinting, classical and 3D cell culture, formation of spheroids / organoids and artificial (bionic) organs, formation of material coatings, and printing of specific tissue models (normal and cancerous), including using blood vessels of cell lines and artificial organs of specific quality, microorganisms (including islets), organoids, spheroids and other three-dimensional cellular structures.

[0042] The materials used in the proposed techniques and their implementations are capable of crosslinking / hardening materials (primarily soft polymers) using UV-VIS radiation without the use of crosslinking-initiating additives, i.e., photoinitiators, metal salts, transition metal complexes and high-valent iodine compounds. The crosslinking of the material, i.e., the functionalized biopolymer obtained by the method according to the invention, occurs due to the [2+2] cycloaddition reaction of compounds containing carbon-carbon multi-bonds and active double or triple bonds, which serve as a separate source of the copolymer or constitute components of the same intramolecular polymer. A schematic diagram of the functionalization process of the biopolymer and its possible subsequent crosslinking pathways is given below. The given pathways are examples, and crosslinking with the material used can occur in any possible manner, resulting from the chemical reaction mechanisms that form the basis of the proposed polymer crosslinking method.

[0043] An important feature of the method is the ability to use light in the UV-Vis range of 280–800 nm, depending on the structure and absorption characteristics of the chromophore substituents located on the multi-bonds where the 2+2 cycloaddition occurs. Shifting the wavelength range to higher wavelengths (lower energy) is not only practical (reducing the energy consumption of the process) but also has significant implications for the use of materials created in this technique for tissue engineering with broad understanding. Radiation near the visible light range has a much smaller damaging effect on cells that may be part of the hardening material.

[0044] The biopolymer functionalization method according to the invention uses compounds containing at least one C=C or C≡C bond (i.e., a bond capable of undergoing a 2+2 cycloaddition reaction). Examples of such compounds are compounds containing a coumarin moiety in their structure, such as coumarin-3-carboxylic acid and coumarin-6-carboxylic acid. These compounds undergo a [2+2] cycloaddition reaction when exposed to light of an appropriate wavelength.

[0045] The following is a scheme for obtaining functionalized biopolymers and then crosslinking them according to the invention:

[0046] (i) Functionalization of biopolymers with compounds containing carbon-carbon multiple bonds (Description 4 / 17, page 6)CN 121100136 A

[0047]

[0048] (ii) Reversible crosslinking of functionalized biopolymers - for variant (a)

[0049]

[0050] Wherein

[0051] Helix = P represents a biopolymer selected from oligopeptides, proteins, and polysaccharides, such as gelatin, hyaluronic acid, alginate, chitosan, dextran, starch, cellulose, collagen, chitin, carrageenan, inulin, glycogen, and heparin;

[0052] X is -OH or -NH2;

[0053] R1, R2, R3, R4, R5, and R6 are each independently of each other H, C1-C30-alkyl, C2-C30-alkenyl, C2-C30-alkynyl, C6-C10-aryl, or C5-C10-heteroaryl containing 1 to 3 heteroatoms selected from N, S, and O.

[0054] The crosslinking in step (ii) is performed using a light beam with a wavelength of 280-800 nm, preferably 365 nm or 405 nm. The exposure time is 1-6000 seconds, preferably 10-360 seconds. The power of the light source used is 1-3000 mW / cm².

[0055] As shown in point (i) of the above scheme, an important advantage of the functionalization of the biopolymer according to the invention is that water gelatin can be crosslinked based on a suitably functionalized polymer soluble in water or buffer without the use of an initiator, and the cyclization reaction can be reversed at a suitably selected wavelength, as shown in point (ii) of the above scheme.

[0056] One of the preferred biopolymers for functionalization using the method according to the invention is gelatin. It is a natural polymer composed of protein chains. Gelatin contains amino acids such as lysine, hydroxylysine, proline, and hydroxyproline, which play a key role in the functionalization reaction because the amino and hydroxyl residues of these amino acids participate in the reaction shown in the following scheme: Specification 5 / 17 Page 7 CN 121100136 A

[0057]

[0058] dECM - decellularized extracellular matrix [Due to the gelatin content in dECM, it can be assumed that the cross-linking mechanism of dECM is similar to that of gelatin]

[0059] R = R1 as defined above

[0060] NHS is N-hydroxysuccinimide

[0061] EDC is 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide

[0062] Another preferred biopolymer for functionalization according to the invention is chitosan. This polysaccharide is a derivative of chitin produced during deacetylation. Chitosan is composed of β-glucosamine molecules linked by β-1,4-glycosidic bonds. The chitosan functionalization reaction involves the free hydroxyl groups present in the deacetylated β-glucosamine unit. The functionalization of chitosan, as with gelatin and dECM, is preferably carried out using an active ester of a suitable carboxylic acid, as shown in the following scheme:

[0063]

[0064] Another preferred biopolymer for functionalization using the method according to the invention is hyaluronic acid. This polysaccharide derived from the glycosaminoglycan group consists of D-glucuronic acid and N-acetyl-D-glucosamine units linked by β-1,4-glycosidic bonds and β-1,3-glycosidic bonds. Functionalization of hyaluronic acid is carried out using the coupling agent DMTMM (4-(4,6-dimethoxy[1,3,5]triazine-2-yl)-4-methylmorpholine chloride). DMTMM is obtained by reacting CDMT (2-chloro-4,6-dimethoxy-1,3,5-triazine) with morpholine. Functionalization of biopolymers can be carried out in two ways. The first way involves the activation of the carboxyl group of the D-glucuronic acid unit, and then the activated carboxyl group reacts with a compound containing an amino or hydroxyl group, as shown in the following scheme:

[0065]

[0066] X-as defined above. Instructions 6 / 17, page 8, CN 121100136 A

[0067] A second method for functionalizing hyaluronic acid involves activating the carboxyl group of any acid with DMTMM, and then reacting the activated acid with the hydroxyl group of an N-acetyl-D-glucosamine unit, as shown in the following scheme:

[0068]

[0069] As described above, one preferred embodiment of the biopolymer functionalization method according to the invention is a two-step reaction using a carboxylic acid derivative constituting the active ester. For this purpose, the carboxylic acid reacts with NHS and a condensing agent such as EDC, DCC, or DIC. The active N-hydroxysuccinimide ester of the carboxylic acid used in this manner reacts with the biopolymer. The active ester reacts with the free amino and hydroxyl groups present in the natural polymer structure to produce a suitable functionalized biopolymer. The active ester can be replaced by an anhydride or acyl chloride of the selected carboxylic acid.

[0070] The degree of substitution of the derivative can be controlled in the range of 20%-100% by controlling the pH, temperature, concentration, and amount of the substrate. The value of the degree of substitution affects the mechanical properties of the obtained material.

[0071] Exemplary Embodiments

[0072] Example 1 - Material Synthesis

[0073] Step 1. Synthesis of Active Esters

[0074] 1.3324 g of coumarin-3-carboxylic acid (CAS: 531-81-7) (4.8 equivalents) and 0.9674 g of N-hydroxysuccinimide (4.8 equivalents) were placed in a round-bottom flask equipped with a stirring element. All substances were dissolved in 12.5 mL of DMF. Then, N,N'-dicyclohexylcarbodiimide (DCC, 4 equivalents) was added to the flask in portions while stirring (1000 rpm). The reaction mixture was allowed to stand at room temperature (25°C, 1000 rpm) for 4 hours. After this, the reaction mixture containing the active ester was filtered through a Schott funnel (G5) and used for the next stage of synthesis.

[0075] Step 2. Functionalization of Gelatin

[0076] Place a three-necked round-bottom flask equipped with a mixing element in the heating block of a magnetic stirrer. Use a funnel to...50 mL of carbonate buffer (CB, pH 9.55) was added and heated to 50 °C. Then, 5 g of gelatin (1 equivalent) was added to the buffer, and the mixture was stirred continuously (1000 rpm). The mixture was completely dissolved (50 °C, 1000 rpm). Then, the DMF solution of the active ester was added dropwise to the solution. The mixture was allowed to stand for 24 hours (50 °C, 1000 rpm). After this, the reaction mixture was diluted with 200 mL of phosphate-buffered saline (PBS xl, pH 7.40) and poured into a 50 mL Falcon tube. The mixture was centrifuged (10000 rpm, 30 min), and the supernatant was filtered through a 0.22 μm filter. The clear solution was dialyzed at 40 °C (12–14 kDa tube) for 3 days, changing the water 3 times daily. The purified solution was frozen and lyophilized (10 °C, 48 h, 0.01 mbar). The product was analyzed by 1H NMR to determine the degree of substitution.

[0077] Synthesis Optimization:

[0078] To optimize the synthesis, a series of experiments were conducted, changing parameters such as: buffer pH, first-stage solvent type (DMF, DMSO, CHCl3), condensation reagent type (EDC and DCC), reaction time (2 hours, 4 hours, 8 hours, 16 hours, 24 hours, 48 ​​hours), and the proportion of reactants in the reaction.

[0079] 1H NMR Analysis: See manual page 7 / 17, CN 121100136 A

[0080] A suitable amount of sample (usually about 5 mg) was weighed and dissolved in 600 μL of deuterated water. 0.0916 mmol of tetramethylsilylpropionic acid (TMSP, quantitative and chemical transfer standard) was added, and the solution was placed in a 5 mm NMR tube. The sample was then placed in an NMR spectrometer (Agilent DirectDrive2 700 MHz). The temperature was set to 60 °C. After the temperature stabilized, the sample was mixed, the probe was adjusted, pulses were measured, and magnetic field inhomogeneity was corrected. Then, the 1H NMR spectrum was measured (measurement parameters: 8 scans, 15 seconds repetition time, 45° 2.5 μs pulse time). Figure 1 shows the 1H NMR spectrum of the material obtained in this embodiment during the crosslinking process of gelatin functionalized with coumarin-3-carboxylic acid.

[0081] Degree of substitution:

[0082] The 1H NMR spectrum of the material was analyzed using the NMRGlue package in the Python environment. After importing the data, the regions of 8.85ppm ÷ 8.6ppm, 1.05ppm ÷ 0.8ppm, and 0.1ppm ÷ 0.1ppm were subjected to exponential weighting (linewidth: 2Hz), Fourier transform, phase and baseline correction. Then, the integral of the peak in the 8.85ppm ÷ 8.6ppm region (corresponding to the proton in the double bond) was calculated.The peaks in the 1.05ppm ÷ 0.8ppm region (peaks from protons of the monomer) were integrated. Based on these parameters, the DSNMR values ​​(degree of substitution) were calculated using the following formula:

[0083]

[0084] The 1H NMR spectrum is shown in Figure 1.

[0085] The functionalization scheme of gelatin is as follows:

[0086]

[0087] A simplified crosslinking scheme of gelatin functionalized with coumarin-3-carboxylic acid (the last step of the above process, P-X- = gelatin) was used:

[0088] Specification 8 / 17 pages 10 CN 121100136 A

[0089] Example 2 - Material Synthesis

[0090] The process is similar to that of Example 1, but in step 1, regardless of whether coumarin-3-carboxylic acid is used to synthesize the active ester, exo-5-norbornene carboxylic acid (CAS: 934-30-5) (in the same molar equivalent amount) was used for the parallel synthesis of the active ester. As a result, two different active esters were obtained and then used in a parallel process in stage 2 (functionalization of gelatin) to obtain appropriately functionalized gelatin derivatives.

[0091] Then, the crosslinking process of the two functionalized gelatin derivatives was carried out together.

[0092] A simplified crosslinking scheme for a mixture of coumarin-3-carboxylic acid-functionalized gelatin and exo-5-norborneol-carboxylic acid-functionalized gelatin solution is shown below, where P-X is gelatin:

[0093]

[0094] Figure 2a shows the 1H NMR spectrum of exo-5-norborneol-carboxylic acid, and Figure 2b shows the 1H NMR spectrum of the material obtained in this example during the crosslinking process of a mixture of 15% solution of coumarin-3-carboxylic acid-functionalized gelatin and 15% solution of exo-5-norborneol-carboxylic acid-functionalized gelatin.

[0095] In this example and Examples 3 and 4 below, solutions of functionalized gelatin were prepared in PBS.

[0096] Example 3 - Material Synthesis

[0097] The process was similar to that of Example 1, but in step 1, regardless of whether coumarin-3-carboxylic acid was used to synthesize the active ester, trans-cinnamic acid (CAS: 140-10-3) was used for the parallel synthesis of the active ester (in the same molar equivalent amount). As a result, two different active esters were obtained, which were then used in the parallel process of stage 2 (functionalization of gelatin) to obtain appropriately functionalized gelatin derivatives.

[0098] Then, the crosslinking process of the two functionalized gelatin derivatives was carried out together.

[0099] A simplified crosslinking scheme for a solution mixture of coumarin-3-carboxylic acid-functionalized gelatin and trans-cinnamic acid-functionalized gelatin is shown below, P-X-gelatin:

[0100]

[0101] Figure 3a shows the 1H NMR spectrum of trans-cinnamic acid, and Figure 3b shows the crosslinking process obtained in this embodiment during the crosslinking of a mixture of a 15% solution of coumarin-3-carboxylic acid-functionalized gelatin and a 10% solution of trans-cinnamic acid-functionalized gelatin.The 1H NMR spectrum of the obtained material.

[0102] Example 4 - Material Synthesis

[0103] The process is similar to that of Example 3, but instead of a mixture of 15% solution of coumarin-3-carboxylic acid-functionalized gelatin and 15% solution of trans-cinnamic acid-functionalized gelatin, the crosslinked material is a mixture of 10% solution of coumarin-3-carboxylic acid-functionalized gelatin and 10% solution of trans-cinnamic acid-functionalized gelatin. Specification 9 / 17 pages 11 CN 121100136 A

[0104] Figure 3c shows the 1H NMR spectrum of the material obtained in this example during the crosslinking process of a mixture of 15% solution of coumarin-3-carboxylic acid-functionalized gelatin and 15% solution of trans-cinnamic acid-functionalized gelatin.

[0105] Example 5 - Determination of Crosslinking Curves

[0106] The experiment included material preparation, digestion of the material using a 0.5% solution of type II collagenase, freeze-drying of the following variants, and 1H NMR analysis:

[0107] Variant 1: Printing four layers of 10×10mm sheet scaffolds for a 15% solution at different crosslinking times (time: 60 seconds, 120 seconds, 240 seconds, 360 seconds, lamp power: 13.0 mW / cm2, wavelength: 365 nm)

[0108] Variant 2: Printing a single layer of 10×10mm sheet scaffolds for 10% and 12.5% ​​solutions at different crosslinking times (time: 120 seconds, 240 seconds, 360 seconds, lamp power: 13.0 mW / cm2, wavelength: 365 nm)

[0109] Solution Preparation

[0110] To prepare a 15% GelCM solution, 1.0515 g of GelCM (coumarin-3-carboxylic acid-functionalized gelatin obtained in Example 1 above) (AZ-041-9) was weighed into a 50 ml bottle using an analytical balance. Then, 5.959 ml of PBS was added using an automated pipette. The bottle containing the solution, wrapped in aluminum foil, was transferred to a hot plate (40°C, 400 rpm) for approximately 30 minutes to dissolve the substance.

[0111] To prepare a 12.5% ​​GelCM solution, 250.0 mg of GelCM (AZ-049-9) was weighed into a 5 ml bottle using an analytical balance. Then, 1.750 ml of PBS was added using an automated pipette. The bottle containing the solution, wrapped in aluminum foil, was transferred to a hot plate (40°C, 400 rpm) for approximately 30 minutes to dissolve the substance. Then, the resulting solution was adjusted to pH 7.37 with 5 μL of 5M NaOH solution.

[0112] To prepare a 10% GelCM solution, 200.0 mg of GelCM (AZ-049-9) was weighed into a 5 ml bottle using an analytical balance. Then, 1800 ml of PBS was added using an automated pipette. The bottle containing the solution, wrapped in aluminum foil, was then transferred...The material was heated to a hot block (40°C, 400 rpm) for about 30 minutes to dissolve it. Then, the resulting solution was adjusted to pH 7.31 with 5 μL of 5M NaOH solution.

[0113] Printing of sheet scaffolds

[0114] Testing was performed using a BioX CELLINK bioprinter and a Polbionica UV-Vis lamp.

[0115] (a) 15% GelCM solution

[0116] Four four-layer 10×10 mm sheet scaffolds were printed from a 10×10×4_05_G4S10 file. Suitable printing parameters (13.5-14℃, 10mm / s, 175kPa) and material crosslinking were also selected:

[0117] P1 .360 s; 365nm; 13.0mW / cm2; P2 .240 s; 365nm; 13.0mW / cm2; P3 .120 s; 365nm; 13.0mW / cm2; P4 .60 s; 365nm; 13.0mW / cm2

[0118] Printing was performed using a 580μm needle (pink plastic needle).

[0119] Figure 4 shows photographs of sheet-like scaffolds printed at different crosslinking times.

[0120] (b) 12.5% ​​GelCM solution

[0121] Three sheet-like scaffolds with dimensions of 10×10×5mm were printed. Appropriate printing parameters (14℃, 81-87kPa, 20mm / s and 15℃, 63-68kPa, 20mm / s) and material crosslinking were also selected:

[0122] Q 5.360 s; 365nm; 13.0mW / cm2; P 6.240 s; 365nm; 13.0mW / cm2; P 7.120 s; 365nm; 13.0mW / cm2

[0123] (c) 10% GelCM solution

[0124] Three sheet-like scaffolds with a size of 10×10×5mm were printed. Suitable printing parameters (14℃, 33-40kPa, 20mm / s and 15℃, 21-27kPa, 20mm / s) and material crosslinking were also selected: Instruction manual 10 / 17 pages 12 CN 121100136 A

[0125] P8.360 s; 365nm; 13.0mW / cm2

[0126] P9.240 s; 365nm; 13.0mW / cm2

[0127] P10.120 s; 365nm; 13.0mW / cm2

[0128] Digestion of sheet scaffolds

[0129] The printed sheet scaffolds were placed in 24-well plates. 1 mL of 0.5% type II collagenase solution was poured into each sheet scaffold and incubated at 37℃ for 48 hours.

[0130] Freeze-drying

[0131] The digested sheet-like scaffold was frozen at -80°C. It was then freeze-dried for 48 hours (15% variant) and 24 hours.(12.5%, 10% variant). Lyophilization conditions: 10°C, 0.01 mbar.

[0132] 1H NMR Analysis

[0133] For 1H NMR analysis, the lyophilized product was weighed into 10 2 mL Eppendorf falcon tubes, and 590 μL of deuterated water and 10 μL of 0.95 mg / mL TMSP standard solution were added. The sample was placed in a hot block (40°C, 400 rpm) and heated for 10 minutes to dissolve the substance. The sample was then injected for 1H NMR analysis (subcontractor Spektrino). Material weights: P1. 6.0 mg; P2. 5.7 mg; P3. 5.9 mg; P4. 5.4 mg; P5. 10.7 mg; P6. 11.5 mg; P7. 11.6 mg; P8. 12.0 mg; P9. 15.5 mg; P10. 17.4 mg.

[0134] Results

[0135] Analytical signals of digested sheet-like scaffolds were found in the 1H NMR spectrum in the ranges of 8.85 ÷ 8.6 ppm and 3.95 ÷ 4.0 ppm. The peak at 8.85 ÷ 8.6 ppm corresponds to the proton at the double bond in the coumarin moiety. As the cyclization reaction of this moiety proceeds, this signal disappears, while a signal appears at 3.95 ÷ 4.0 ppm, which corresponds to the proton at the cyclobutane ring formed in the cyclization reaction of the coumarin moiety. The presence of the signal in the range of 3.95 ÷ 4.0 ppm proves that the GelCM material is crosslinked under the influence of UV-Vis radiation.

[0136] The 1H NMR measurements were analyzed, and the percentage of unreacted coumarin-3-carboxylic acid groups (DS of the crosslinked material) was determined according to the following formula, taking into account the monomer (mer) content (lysine residues) in the sample:

[0137]

[0138] The percentage of unreacted species was converted to the degree of crosslinking of the material, taking into account the degree of substitution of the non-crosslinked material (DS of the starting material). The results are summarized in the following table:

[0139] Table 1: Summary of 1H NMR Analysis Results - Values ​​of Substitution Degree (DS) of Crosslinked Materials

[0140] Specification 11 / 17 pages 13 CN 121100136 A

[0141]

[0142] Figure 5 shows the 1H NMR spectrum of a 15% GelCM solution (a), Figure 6 shows the 1H NMR spectrum of a 12.5% ​​GelCM solution (b), and Figure 7 shows the 1H NMR spectrum of a 10% GelCM solution (c).

[0143] Conclusion

[0144] 1H NMR analysis shows that the longer the crosslinking time, the higher the degree of crosslinking of the material for each concentration variant. The highest degree of crosslinking was obtained with the following crosslinking parameters: 360 seconds, 13.0 mW / cm2, 365 nm. These parameters were used for subsequent material testing.

[0145] Example 6 - Printability

[0146] Solution Preparation

[0147] (i) 15% (w / w) GELCM

[0148] A 2.5 ml 15% (w / w) GELCM solution (AZ-057-9, DS = 50%) was prepared.

[0149] 378.6 mg of lyophilized GELCM was weighed on a weighing container using an analytical balance. The weighed lyophilized GELCM was then transferred to a 5 ml Falcon tube and 2.145 ml of PBS was added. The GELCM solution was placed in a hot block (50°C, 400 rpm) for 30 minutes. After the GELCM was completely dissolved, the pH of the solution was checked (pH 0 = 6.55) and adjusted to pH = 7.39 (5 ​​μl of 5M NaOH and 1.5 μl of 5M HCl were added). The prepared solution was filtered into a 5 ml sterile aluminum foil-wrapped Falcon tube using a 0.22 μm syringe filter.

[0150] (ii) 12.5% ​​(w / w) GELCM

[0151] A 2.5 ml 12.5% ​​(w / w) GELCM solution (AZ-057-9, DS = 50%) was prepared.

[0152] 318.8 mg of lyophilized GELCM was weighed on a weighing container using an analytical balance. The weighed lyophilized GELCM was then transferred to a 5 ml falcon tube and 2.232 ml of PBS was added. The GELCM solution was placed in a hot block (50°C, 400 rpm) for 30 minutes. After the GELCM was completely dissolved, the pH of the solution was checked (pH 0 = 6.58), and the value was adjusted to pH = 7.39 (by adding 4 μl of 5M NaOH and 0.5 μl of 5M HCl). The prepared solution was filtered into a 5 ml sterile aluminum foil-wrapped falcon tube using a 0.22 μm syringe filter.

[0153] (iii) 10% (w / w) GELCM

[0154] A 2.5 ml 10% (w / w) GELCM solution (AZ-057-9, DS = 50%) was prepared.

[0155] 254.3 mg of lyophilized GELCM was weighed on a weighing container using an analytical balance. The weighed lyophilized GELCM was then transferred to a 5 ml falcon tube and 2.289 ml of PBS was added. The GELCM solution was placed in a hot block (50°C, 400 rpm) for 30 minutes. After the GELCM was completely dissolved, the pH of the solution was checked (pH 0 = 6.66), and the value was adjusted to pH = 7.43 (by adding 3 μl of 5M NaOH and 0.5 μl of 5M HCl). The prepared solution was filtered into a 5 ml sterile aluminum foil-wrapped falcon tube using a 0.22 μm syringe filter. (iv) 10% (w / w) GELMA + 0.25% (w / w) LAP

[0157] A 2.5 ml 10% (w / w) GELMA solution (P10-01, DS = 81 / 86%) was prepared.

[0158] Using an analytical balance, 318.8 mg of lyophilized GELMA was weighed in a weighing container. The weighed lyophilized GELMA was then transferred to a 5 ml Falcon tube, and 2.291 ml of PBS was added. The GELMA solution was placed in a hot block (50°C, 400 rpm) for 30 minutes. Then, after dissolving the GELMA, 6.5 mg of LAP, weighed in a weighing bottle, was transferred to the Falcon tube along with the solution. After the GELMA was completely dissolved in LAP, the pH of the solution was checked (pH 0 = 7.33). The prepared solution was filtered through a 0.22 μm syringe filter into a 5 ml sterile aluminum foil-wrapped Falcon tube.

[0159] Printability Testing

[0160] Printability testing was performed using a BioX CELLINK bioprinter. The printing parameters for each material are listed in Table 2 below. The parameters used allow for the production of uniform, dense fibers. The procedure for performing the printability testing was based on a literature review (Ahasan Habib, Venkatachalem Sathish, Sanku Mallik, Bashir Khoda, 3D Printability of Alginate-Carboxymethyl Cellulose Hydrogel Materials (Basel) 2018 Mar 20; 11(3):454. doi:10.3390 / ma11030454).

[0161] Table 2. Printing parameters in the printability testing of pre-crosslinked materials

[0162]

[0163]

[0164] The proposed techniques include extrusion printing, volumetric printing, and other printing techniques that require appropriate material viscosity to produce uniform, coherent fibers while maintaining print resolution. Printing temperatures can range from 5°C to 50°C, depending on the material used. Extrusion printing pressures range from 5 to 150 kPa. Printing speeds range from 1 to 100 mm / s. Needle diameters range from 50 to 900 μm. Printed models can include any size expressed in mm, and infill sizes from 5% to 100%, resulting in cutout printing.

[0165] Fiber Bonding Test

[0166] A suitable g-code was prepared for the fiber bonding test: template.gcode, which assumes that two layers are printed one after another using the test material without the use of an external lamp for cross-linking. The test was performed using a BioX CELLINK printer.Printing. Printing followed a pattern following a 0°–90° pattern, which produced a 2D effect and increased the distance between fibers. The distance between fibers ranged from 1 to 5 mm in 1 mm increments. The printing speed, needle diameter, and extrusion width used in the tests were 10 mm / s, 25 G (0.250 mm), and 0.3 mm, respectively. During the tests, material was supplied quantitatively within the appropriate pressure and temperature ranges given in Table 2 above. The prints were crosslinked using an external UV-Vis lamp (Polbionica) with the following parameters: wavelength 365 nm, time 360 ​​s, power 13 mW / cm² for GELCM; and wavelength 405 nm, crosslinking time 30 s, power 28.5 mW / cm² for GELMA. Micrographs were taken after printing. The images were processed using ImageJ software. Based on the results, two parameters described by the following equations were determined: the percentage of diffusion rate (Dfr, material diffusion rate) and printability (Pr). The diffusion rate of a hole with no material diffusion is 0 (i.e., At = Aa), and the printability is 1.0 for a perfect model representation. Specification 13 / 17 pages 15 CN 121100136 A

[0167]

[0168] At—theoretical hole surface area,

[0169] Aa—actual hole surface area,

[0170] L—actual circumference of the hole.

[0171] Figure 8 shows the scheme of the g.code file [template.gcode]

[0172] Fiber Bending Test

[0173] The mid-span bending of the suspended fiber was analyzed to determine the collapse of the material. For the experiment, a special platform consisting of seven pillars was designed, which were spaced apart from each other at known distances of 1, 2, 3, 4, 5, and 6 mm. The five pillars located within the structure have a size of 2 × 10 × 6 mm³, and the two edge pillars have a size of 5 × 10 × 6 mm³. According to g-code:MR_test1.geode, a single fiber of the test material was placed on the platform, and a photograph of the print was taken immediately. The photograph was processed using ImageJ software. During this process, the temperature and pressure conditions were adjusted according to the test material, and printing was performed using a 25G (0.250mm) needle at a speed of 10mm / s. The collapse area coefficient Cf is the percentage of the actual area to the theoretical area after bending and suspending the fiber.

[0174]

[0175] Aa c—theoretical area under the curve,

[0176] At c—actual area under the curve.

[0177] Figure 9 shows a schematic diagram of the fiber bending test platform.

[0178] Results

[0179] For each material variant, three fiber bonding tests were performed. Then, a micrograph of the obtained construct was taken, as shown in Figure 10. Based on the obtained measurements, the percentage of fiber diffusion rate Dfr and printability Pr were calculated, and the results were obtained.The results are represented by the curves shown in Figures 11 and 12, respectively.

[0180] Conclusion

[0181] All tested materials exhibited continuous, dense fibers, which allowed for printing with good resolution. A 1×1 mm hole could not be printed in any of the tested materials (the exception was the second attempt to print 15% (w / w) GELCM, which produced a small hole). For each material variant, printability above 0.8 and diffusion rate percentage below 50% were achieved. The diffusion rate decreased with increasing hole size. Except for the 1×1 hole, printability for each hole size was at the level of 0.8–0.9 for all materials. 15% (w / w) GELCM and 10% (w / w) GELMA + 0.25% (w / w) LAP showed the best printability. 12.5% ​​GELCM showed the lowest diffusion percentage in 4×4 and 5×5 wells, while the reference material 10% (w / w) GELMA + 0.25% (w / w) LAP showed the lowest diffusion percentage in 2×2 and 3×3 wells.

[0182] Example 4 - Study on Cell Proliferation and Toxicity

[0183] Almar Blue Test

[0184] This method is based on converting a compound called alpha blue (Resazurin) into a resorufin compound along with live cells. Resazurin is known to be a redox blue dye that freely enters cells through the cell membrane, where it is reduced and converted into the fluorescent pink resorufin. Dead cells cannot reduce resazurin and cannot produce a fluorescent signal due to loss of metabolic activity. The signal obtained was detected using a fluorometer, and the intensity increased with the increase of the number of live cells.

[0185] Figure 13 shows the Almar Blue test results of cells printed with Gelcm 10%, 12.5%, and 15% and Gelma 10% constructs. The control group consisted of L929 cells directly seeded onto the plate without any biomaterial. Measurements were taken at four time points: the day of printing and days 3, 7, and 14 post-printing.

[0186] Conclusions

[0187] Cell proliferation levels were similar in the 10% and 12% Gelcm biomaterials. The degree of cell proliferation (reduction in population growth rate) in 15% Gelcm was significantly lower than that in the other biomaterials. The results indicate that cell proliferation was highest in 10% Gelcm during the first few hours of the experiment, and cells became less prone to division over time compared to K or 10% and 12.5% ​​Gelcm.

[0188] Microscopic observation

[0189] I. Imaging of biomaterials with cells in a bright field

[0190] After printing, the construct was transferred to a multi-well plate and imaged under a bright-field Olympus microscope using a 10x objective lens.

[0191] II. Imaging of Biomaterials with Cells After FDA / Pi Staining

[0192] Cell viability was assessed based on FDA / Pi staining according to the developed procedure, in which two fluorescent dyes, propidium iodide (PI) and fluorescein diacetate (FDA), were used for cell staining (to distinguish between dead and live cells). FDA can penetrate the cell membrane. Once inside the cell, FDA is hydrolyzed by intracellular esterases into fluorescein, which exhibits fluorescent properties. Live cells can accumulate this compound, enabling them to emit strong green fluorescence. Propidium iodide carries a charge and does not penetrate intact cell membranes. It stains necrotic or late-stage apoptotic cells red. Samples were suspended in 1x PBS (stained with FDA / PI and observed immediately under a fluorescence microscope. Two staining solutions were prepared: FDA (5 mg / ml acetone solution) and PI (2 mg / ml PBS solution).

[0193] Figure 14 shows a microscopic image of the printed construct with L929 cells immediately after the printing process, Figure 15 shows a microscopic image of the printed construct with L929 cells on day 3 of the experiment, and Figure 16 shows a microscopic image of the printed construct with L929 cells on day 7 of the experiment.

[0194] Summary

[0195] In the test group: 10% Gelcm, 12.5% ​​Gelcm, and 10% Gelcm, L929 cells showed high levels of viability. High levels of viability, exceeding 90%, were observed over the following days, and cells printed in the following biomaterials developed normally: 10% Gelcm, 12.5% ​​Gelcm, and 10% Gelma (as reference material).

[0196] Cytotoxicity of GelCM Biomaterials Assessed Using LDH Release Assay

[0197] The purpose of the experiment was to assess the cytotoxicity of the biomaterials GelCM 10%, GelCM 12.5%, and GelCM 15% (batch GelCM AZ-050-9). The cytotoxicity of the biomaterials was tested using a assay based on the lactate dehydrogenase (LDH) activity assay of the mouse fibroblast cell line L-929 (cat no: CCL-1TM).

[0198] Lactate Dehydrogenase (LDH) Activity Assay - Method Principle

[0199] Cytotoxicity (cytotoxic activity) refers to the ability of a specific factor (chemical, physical, or biological) to disrupt cellular function. It also involves inhibiting its growth, proliferation, or inducing cell death, etc. [Abe K., Matsuki N., Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT],Neurosci Res.2000;38(4):325‑9.]. Currently, there are many tests on the market to determine cell viability after exposure to test substances, including the MTT assay (MTT is 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide), the neutral red assay (NR), or the measurement of the activity of the cytoplasmic enzyme lactate dehydrogenase (LDH) [Abe K., Matsuki N., Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT, NeurosciRes.2000;38(4):325-9; Jost LM, Kirkwood JM, Whiteside TL, Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells, J Immunol Methods. 1992; 147(2): 153-65; Wang S., Yu H., Wickliffe J.K., Limitation of the MTT and XTT assays for measuring cellviability due to superoxide formation induced by nano-scale TiO2, ToxicolVitr. 2011; 25(8): 2147-51.].

[0200] Lactate dehydrogenase (LDH) is a soluble, stable intracellular enzyme that is released into the culture medium when the integrity of the cell membrane is impaired. The released enzyme can be detected by various methods, such as colorimetry, fluorescence, or luminescence (the most sensitive method). In our own study, we used Promega’s commercial LDH-Glo™ cytotoxicity assay kit, which is based on bioluminescence to quantify the released LDH.

[0201] LDH released from damaged cells catalyzes the oxidation of lactate to pyruvate, while NAD+ is reduced to NADH. The reductase uses NADH and its substrate to produce luciferin, which is then converted by rLuciferase.Ultra-Glo™ is converted into a bioluminescent signal. The generated luminescent signal is proportional to the amount of LDH present [Holmes RS, Goldberg E. Computational analysis of mammalian lactate dehydrogenases: human, mouse, opossum and platypus LDHs. Comput Biol Chem. 2009 Oct; 33(5):379-85; Khan AA, Allemailem KS, Alhumaydhi FA, Gowder SJT, Rahmani AH. The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism. Endocr Metab Immune Disord Drug Targets. 2020; 20(6):855-868]. The determination of LDH activity in the supernatant is a measure of the toxicity of the test substance to cultured cells. This method allows us to clearly determine whether a given substance will damage the cell membrane, leading to cell death.

[0202] Preparation of Biomaterials for LDH Testing

[0203] Four biomaterials were received from the bioprinting team: GELMA 10% (Gelma batch P10-01), GelCM 10%, GelCM 12.5%, and GelCM 15% (GelCM batch AZ-050-9), with printed mouse fibroblasts. Each biomaterial was printed three times. 5 × 10⁶ cells were used for printing per 1 ml of given bioink. The bioconstructs were placed in 6-well plates in DMEM medium (total volume of 4 ml). Throughout the experiment, the constructs were stored under standard culture conditions, i.e., 37°C and 5% CO₂. The controls in the experiment were: L-929 cells alone as a negative control, L-929 cells treated with 0.1% Triton X-100 as a positive control, and cell-free printouts. Figure 17 shows a photograph of the biomaterial containing L-929 cells after transfer to a 6-well plate containing supplemental culture medium: A-GELMA 10%, GelCM 12.5%, GelCM 15%, and B-GelCM 10%.

[0204] LDH Assay Procedure

[0205] The tested biomaterial was evaluated using an LDH assay.15% toxicity to L-929 cells. The test was performed at four time points—days 1, 5, 7, and 14. For the test, culture medium samples were collected (on days 1, 5, 7, and 14) and diluted 1:100 in sample storage buffer (LDH storage buffer). One study consisted of three replicates (three replicates printed with one type of biological material). Samples were stored at -20°C prior to the test. Before starting the test, the reaction mixture was prepared according to the manufacturer's recommendations: 50 μl of LD detection enzyme mixture (instructions page 16 / 17, 18 CN 121100136 A) and 0.25 μl of reductase substrate / sample. A series of dilutions of LDH standards were also performed. The reaction mixture was spotted 1:1 with the test sample onto white 96-well plates. The plates were incubated at room temperature for 60 minutes, and then the luminescence was read using a microplate reader.

[0206] LDH Release Analysis

[0207] Figure 18 shows the percentage of lactate dehydrogenase (LDH) released from L-929 cells as a result of interaction with the test biomaterial for 1, 5, 7, and 14 days. LDH enzyme activity results are expressed as a percentage relative to the positive control group (K+).

[0208] Figure 19 shows photomicrographs of L-929 cell cultures after 14 days of incubation with biomaterials of 10% GelCM, 12.5% ​​GelCM, 15% GelCM, and 10% GELMA. These photomicrographs were taken in bright field (BF) using an Olympus IX83 microscope at magnifications of 4x, 10x, and 20x.

[0209] Observations and Conclusions:

[0210] All biomaterials resulted in increased cytotoxicity over time, i.e., the level of LDH in the culture medium increased with prolonged incubation time of cells in a given biomaterial. Exposing cells to GelCM 10%, GelCM 12.5%, and GelCM 15% for 7 days resulted in LDH release levels below 30%. Microscopic observation showed that until day 7, the cell morphology was normal (spindle-shaped, granular, and normally confluent). Instruction manual, page 17 / 17, 19 CN 121100136 A, Figure 1; Instruction manual, Figure 1 / 15, page 20 CN 121100136 A, Figure 2a, Figure 2b; Instruction manual, Figure 2 / 15, page 21 CN 121100136 A, Figure 3a, Figure 3b; Instruction manual, Figure 3 / 15, page 22 CN 121100136 A, Figure 3c; Instruction manual, Figure 4 / 15, page 23 CN 121100136 A, Figure 4; Instruction manual, Figure 5 / 15, page 24 CN 121100136 A, Figure 5; Instruction manual, Figure 6 / 15, page 25 CN 121100136 A, Figure 6.Figure 7 of the instruction manual, page 26 of 121100136 A; Figure 8 of the instruction manual, page 27 of 121100136 A; Figure 8 of the instruction manual, page 28 of 121100136 A; Figure 10 of the instruction manual, page 10 of 121100136 A; Figure 11 of the instruction manual, page 12 of 121100136 A; Figure 12 of the instruction manual, page 13 of 121100136 A; Figure 14 of the instruction manual, page 15 of 121100136 A; Figure 18 of the instruction manual, page 14 of 121100136 A; Figure 19 of the instruction manual, page 15 of 121100136 A; Figure 19 of the instruction manual, page 15 of 121100136 A; Figure 10 of the instruction manual, page 15 of 121100136 A; Figure 11 of the instruction manual, page 121100136 A; Figure 19 of the instruction manual, page 15 of 121100136 A; Figure 10 of the instruction manual, page 15 of 121100136 A; Figure 10 of the instruction manual, page 15 of 121100136 A; Figure 11 of the instruction manual, page 121100136 A; Figure 12 of the instruction manual, page 15 of 121100136 A; Figure 10 of the instruction manual, page 15 of ...

Claims

1. A method for functionalizing biopolymers, characterized in that, A biopolymer having a -OH or -NH2 group reacts with at least one compound containing at least one C=C or C≡C bond and a chromophore that absorbs UV-Vis radiation directly adjacent to the bond.

2. The method according to claim 1, wherein the compound containing at least one C=C or C≡C bond is a carboxylic acid derivative, preferably selected from active esters, acid anhydrides, and acyl chlorides.

3. The method according to claim 2, wherein the carboxylic acid derivative is selected from coumarin-3-carboxylic acid derivatives, exo-5-norbornene carboxylic acid derivatives, and trans-cinnamic acid derivatives.

4. The method according to claim 2 or 3, wherein the active ester is an N-hydroxysuccinimide ester, which is obtained by reacting a carboxylic acid containing at least one C=C or C≡C bond with an N-hydroxysuccinimide in the presence of a coupling agent, wherein the coupling agent is preferably selected from 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), dicyclohexyl-carbodiimide (DCC), and N,N'-diisopropylcarbodiimide (DIC).

5. The method according to any one of claims 1-4, wherein the biopolymer is selected from proteins and polysaccharides.

6. The method according to claim 5, wherein the biopolymer is selected from gelatin, hyaluronic acid, alginate, chitosan, dextran, starch, cellulose, collagen, chitin, carrageenan, inulin, glycogen, and heparin, preferably selected from gelatin, chitosan, and hyaluronic acid, and most preferably gelatin.

7. A method for obtaining solid biopolymer materials, characterized in that, The functionalized biopolymer obtained by the method of any one of claims 1-6 undergoes reversible crosslinking when exposed to light in the UV-VIS range, preferably in the light range of 280-800 nm, and most preferably in the light range of 365 nm and 405 nm.

8. Use of the functionalized biopolymer obtained by the method of any one of claims 1-6 as a support material for 3D bioprinting.

9. Use of the functionalized biopolymer obtained by the method of any one of claims 1-6 for preparing structures selected from spheres, organoids, artificial organs, membranes, and tissue models.